Last reviewed · How we verify
Triple Negative Breast Cancer
Approved treatments
- Azd5363 · Pfizer
Pipeline
- CROMOLYN SODIUM — Phase 2
- ZEN003694 · Pfizer Inc. — discontinued
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Triple Negative Breast Cancer patent landscape — cliff calendar, originator estates, attackable patents
- Triple Negative Breast Cancer treatment landscape brief
- Triple Negative Breast Cancer treatment updates RSS
Frequently asked questions about Triple Negative Breast Cancer
What drugs treat Triple Negative Breast Cancer?
Tracked treatments include Azd5363.
What is the treatment for Triple Negative Breast Cancer?
Standard treatment for Triple Negative Breast Cancer includes Azd5363. See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Triple Negative Breast Cancer?
2 pipeline drugs tracked. Top candidates: CROMOLYN SODIUM, ZEN003694.
Related
- Treatment landscape: Triple Negative Breast Cancer patent cliff · Triple Negative Breast Cancer CI report
- Treatment: Azd5363 · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing